Want to see IN:MEDICO full AI Analyst Report?

Medico Remedies Ltd. (MEDICO) Price & Analysis

0 Followers

MEDICO Stock Chart & Stats

₹50.16

₹4.58(8.10%)

At close: Jan 08 4:00 PM EST

₹50.16

₹4.58(8.10%)

Day’s Range― - ―

52-Week Range₹31.00 - ₹56.99

Previous CloseN/A

Volume2.72M

Average Volume (3M)17.09K

Market Cap

₹2.81B

Enterprise Value₹2.86K

Total Cash (Recent Filing)₹37.51M

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)19.6

Beta0.26

Next Earnings

Nov 12, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)1.67

Shares Outstanding82,984,000

10 Day Avg. Volume23,571

30 Day Avg. Volume17,089

Financial Highlights & Ratios

PEG Ratio0.70

Price to Book (P/B)3.60

Price to Sales (P/S)1.32

P/FCF Ratio-78.06

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Accelerating Revenue And Profit GrowthConsistent revenue expansion alongside substantial multi-year net income growth indicates strengthening business scale and improving earnings capacity. If this trajectory persists, the company can build a larger operating base and generate greater resources for reinvestment over the next several quarters.

Compounding Equity And Manageable LeverageSteadily compounding equity provides a stronger capital foundation for asset growth and reduces reliance on leverage. The historical improvement in debt-to-equity also suggests that expansion has generally been supported by a healthier balance sheet, despite a recent borrowing increase.

Strong And Stable Returns On EquitySustained returns on equity indicate that management has been using shareholder capital efficiently across several reporting years. This supports the durability of the company’s profitability profile and suggests that growth has not been accompanied by a prolonged deterioration in capital productivity.

Bears Say

Weak And Unreliable Cash ConversionThe sharp decline in operating cash flow despite rising profit raises concerns about earnings conversion and working-capital intensity. Negative free cash flow may require greater reliance on borrowing or other funding, limiting financial flexibility and reducing the quality of near-term earnings growth.

Volatile Gross And Operating MarginsMargin inconsistency makes future earnings less predictable even when revenue continues to grow. Fluctuating gross and operating profitability can weaken the company’s ability to convert sales growth into durable cash earnings, making sustained improvement dependent on better operating stability.

Recent Increase In BorrowingsThe renewed increase in debt adds a financial risk to an expansion strategy that is already producing inconsistent cash flow. Higher borrowings can reduce flexibility if operating cash generation remains weak, while also making future growth more dependent on successful asset and profit expansion.

Medico Remedies Ltd. News

Medico Remedies Announces 31st AGM Details

Medico Remedies Ltd. ( ($IN:MEDICO) ) has provided an update. Medico Remedies Limited has announced the completion of...

1y ago

MEDICO FAQ

What was Medico Remedies Ltd.’s price range in the past 12 months?

Medico Remedies Ltd. lowest stock price was ₹31.00 and its highest was ₹56.99 in the past 12 months.

What is Medico Remedies Ltd.’s market cap?

Medico Remedies Ltd.’s market cap is ₹2.81B.

When is Medico Remedies Ltd.’s upcoming earnings report date?

Medico Remedies Ltd.’s upcoming earnings report date is Nov 12, 2026 which is in 48 days.

How were Medico Remedies Ltd.’s earnings last quarter?

Medico Remedies Ltd. released its earnings results on Aug 13, 2026. The company reported ₹0.303 earnings per share for the quarter.

Is Medico Remedies Ltd. overvalued?

According to Wall Street analysts Medico Remedies Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Medico Remedies Ltd. pay dividends?

Medico Remedies Ltd. does not currently pay dividends.

What is Medico Remedies Ltd.’s EPS estimate?

Medico Remedies Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Medico Remedies Ltd. have?

Medico Remedies Ltd. has 82,984,000 shares outstanding.

What happened to Medico Remedies Ltd.’s price movement after its last earnings report?

Medico Remedies Ltd. reported an EPS of ₹0.303 in its last earnings report. Following the earnings report the stock price went up 0.776%.

Which hedge fund is a major shareholder of Medico Remedies Ltd.?

Currently, no hedge funds are holding shares in IN:MEDICO

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Medico Remedies Ltd.

Medico Remedies Ltd. engages in the manufacture, supply, and exportation of pharmaceutical drugs. Its product portfolio includes general formulations, which consists of general tablets, capsules, and dry syrups; and beta lactum formulations, which comprises penicillin and cephalosporin range of formulations in tablets, capsules, and dry syrups. The company was founded on March 18, 1994 and is headquartered in Thane, India.